Predictive Oncology Gross Margin 2010-2024 | POAI
Current and historical gross margin for Predictive Oncology (POAI) over the last 10 years. The current gross profit margin for Predictive Oncology as of December 31, 2024 is %.
| Predictive Oncology Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $0.00B | 0 | 0.00% |
| 2024-09-30 | $0.00B | 0 | 0.00% |
| 2024-06-30 | $0.00B | $0.00B | 100.00% |
| 2024-03-31 | $0.00B | $0.00B | 100.00% |
| 2023-12-31 | $0.00B | $0.00B | 100.00% |
| 2023-09-30 | $0.00B | $0.00B | 100.00% |
| 2023-06-30 | $0.00B | 0 | 0.00% |
| 2023-03-31 | $0.00B | 0 | 0.00% |
| 2022-12-31 | $0.00B | 0 | 0.00% |
| 2022-09-30 | $0.00B | 0 | 0.00% |
| 2022-06-30 | $0.00B | 0 | 0.00% |
| 2022-03-31 | $0.00B | 0 | 0.00% |
| 2021-12-31 | $0.00B | 0 | 0.00% |
| 2021-09-30 | $0.00B | 0 | 0.00% |
| 2021-06-30 | $0.00B | 0 | 0.00% |
| 2021-03-31 | $0.00B | 0 | 0.00% |
| 2020-12-31 | $0.00B | 0 | 0.00% |
| 2020-09-30 | $0.00B | 0 | 0.00% |
| 2020-06-30 | $0.00B | 0 | 0.00% |
| 2020-03-31 | $0.00B | 0 | 0.00% |
| 2019-12-31 | $0.00B | 0 | 0.00% |
| 2019-09-30 | $0.00B | 0 | 0.00% |
| 2019-06-30 | $0.00B | 0 | 0.00% |
| 2019-03-31 | $0.00B | 0 | 0.00% |
| 2018-12-31 | $0.00B | 0 | 0.00% |
| 2018-09-30 | $0.00B | 0 | 0.00% |
| 2018-06-30 | $0.00B | 0 | 0.00% |
| 2018-03-31 | $0.00B | 0 | 0.00% |
| 2017-12-31 | $0.00B | 0 | 0.00% |
| 2017-09-30 | $0.00B | 0 | 0.00% |
| 2017-06-30 | $0.00B | 0 | 0.00% |
| 2017-03-31 | $0.00B | 0 | 0.00% |
| 2016-12-31 | $0.00B | 0 | 0.00% |
| 2016-09-30 | $0.00B | 0 | 0.00% |
| 2016-06-30 | $0.00B | 0 | 0.00% |
| 2016-03-31 | $0.00B | 0 | 0.00% |
| 2015-12-31 | $0.00B | 0 | 0.00% |
| 2015-09-30 | $0.00B | 0 | 0.00% |
| 2015-06-30 | $0.00B | 0 | 0.00% |
| 2015-03-31 | $0.00B | 0 | 0.00% |
| 2014-12-31 | $0.00B | 0 | 0.00% |
| 2014-09-30 | $0.00B | 0 | 0.00% |
| 2014-06-30 | $0.00B | 0 | 0.00% |
| 2014-03-31 | $0.00B | 0 | 0.00% |
| 2013-12-31 | $0.00B | 0 | 0.00% |
| 2013-09-30 | $0.00B | 0 | 0.00% |
| 2013-06-30 | $0.00B | 0 | 0.00% |
| 2013-03-31 | $0.00B | 0 | 0.00% |
| 2012-12-31 | $0.00B | 0 | 0.00% |
| 2012-09-30 | $0.00B | 0 | 0.00% |
| 2012-06-30 | $0.00B | 0 | 0.00% |
| 2012-03-31 | $0.00B | 0 | 0.00% |
| 2010-03-31 | $0.00B | 0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.010B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.971B | 53.83 |
| Hims & Hers Health (HIMS) | United States | $11.505B | 119.54 |
| Tempus AI (TEM) | United States | $11.232B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.506B | 70.41 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Privia Health (PRVA) | United States | $3.041B | 208.92 |
| Clover Health Investments (CLOV) | United States | $1.916B | 0.00 |
| Enovis (ENOV) | United States | $1.889B | 10.53 |
| Schrodinger (SDGR) | United States | $1.744B | 0.00 |
| Phreesia (PHR) | United States | $1.492B | 0.00 |
| Azenta (AZTA) | United States | $1.266B | 58.96 |
| Omnicell (OMCL) | United States | $1.189B | 20.98 |
| 10x Genomics (TXG) | United States | $1.055B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.565B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.512B | 152.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.424B | 0.00 |
| TruBridge (TBRG) | United States | $0.374B | 833.33 |
| Claritev (CTEV) | United States | $0.350B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.293B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.211B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.199B | 0.00 |
| Pulmonx (LUNG) | United States | $0.147B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.146B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.094B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.086B | 0.00 |
| CareCloud (CCLD) | United States | $0.078B | 2.97 |
| 111 (YI) | China | $0.066B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.061B | 0.00 |
| Outset Medical (OM) | United States | $0.057B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |